Tysabri Infusion Therapy for MS Treatment: How It Works & Side-Effects

If you live with multiple sclerosis (MS), you’ve probably heard someone casually drop the name
Tysabri into the conversation, the way others talk about their favorite coffee shop.
Unlike coffee, though, this is a serious, high-efficacy infusion therapy designed to calm down an
overexcited immune system and help prevent MS relapses.

Tysabri (generic name natalizumab) is an intravenous (IV) medication that’s usually
reserved for people with very active relapsing forms of MS. It’s powerful, it can be life-changing,
and yesit comes with some big warnings that deserve your full attention. Think of it as a “VIP
treatment” that also comes with a multi-page contract in tiny print.

In this guide, we’ll break down how Tysabri infusion therapy works, what infusion days are like,
common and serious side effects, safety monitoring, and what real-life experiences on Tysabri can feel
like. We’ll also touch on alternatives and how to talk with your neurologist about whether this
treatment fits into your long-term MS strategy.

Important note: This article is for information and education only. It’s not medical advice, a diagnosis,
or a treatment plan. Always talk with your neurologist or MS specialist before starting, stopping, or changing
any medication.

What Is Tysabri Infusion Therapy?

Tysabri is a disease-modifying therapy (DMT) used to treat relapsing forms of multiple sclerosis,
including clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS. It’s given as
a 300 mg IV infusion over about one hour every four weeks in a clinic or infusion center, followed
by an observation period, especially during the early months of treatment.

In the United States, Tysabri is considered a high-efficacy option, often used when:

• You have very active MS with frequent relapses or new MRI lesions, or
• You’ve tried other MS therapies but still have breakthrough disease activity.

Because of its risk profileparticularly the risk of a rare brain infection called progressive multifocal
leukoencephalopathy (PML)Tysabri can only be given in the U.S. through a special safety program called the
TOUCH Prescribing Program, which tracks patients and helps ensure careful monitoring.

How Tysabri Works in the Body

MS is an autoimmune disease where your immune system mistakenly attacks the protective myelin coating around nerves
in your brain and spinal cord. That damage can lead to symptoms like numbness, weakness, vision changes, balance
problems, fatigue, and more.

Tysabri is a monoclonal antibody. In simple terms, it’s a lab-made protein designed to target a
specific “address label” on certain white blood cells. More specifically, it binds to a protein called
α4-integrin on immune cells. By doing this, Tysabri helps prevent those cells from sticking to the
blood vessel walls and crossing the blood–brain barrier into the central nervous system.

If you like analogies, imagine a bouncer at an exclusive club (your brain and spinal cord). Tysabri tells the
bouncer, “Anyone with this badge? Don’t let them in.” Fewer inflammatory immune cells sneaking into the club means
less damage to myelin and fewer relapses.

Clinical studies and real-world data show that Tysabri can:

• Reduce annual relapse rates by about two-thirds in people with relapsing MS
• Reduce the number of new or enlarging MRI lesions
• Help slow the accumulation of disability for many patients over time

Because it works differently from many other MS medications, Tysabri is often considered when rapid and robust
control of disease activity is needed.

What to Expect on Tysabri Infusion Day

Before You Start: Screening and Baseline Checks

Before you receive your first Tysabri infusion, your healthcare team typically:

• Reviews your full medical history and prior MS treatments
• Checks for past use of immunosuppressant drugs (which can affect PML risk)
• Orders baseline brain MRI scans
• Performs blood tests, including JC virus (JCV) antibody testing, which helps
  estimate your risk of PML
• Might run additional labs such as liver function tests or pregnancy testing where appropriate

You’ll also review and sign paperwork for the TOUCH Prescribing Program, confirming you understand the benefits and
risks of treatment.

During the Infusion

A typical Tysabri infusion visit goes something like this:

1. Check-in and vitals. The nurse will verify your identity, review any new symptoms, and check vital signs.
2. IV placement. An IV line is placed, usually in a vein in your arm or hand.
3. Infusion. The 300 mg dose of Tysabri is usually delivered over about one hour by IV pump.
4. Observation period. After the infusion, staff monitor you for signs of hypersensitivity or allergic reaction. Typically,
   this observation lasts for about an hour early in treatment, and may be shortened after a series of uneventful infusions, depending on your provider’s judgment.

Some people bring a book, headphones, or even a laptop. Think of it as a once-a-month enforced “sit still and
hydrate” appointmentwith extra lab-coat supervision.

After the Infusion

Many people feel completely fine after infusion and go about their day. Others may feel:

• Mild fatigue
• Headache
• Slight flu-like symptoms

These usually fade within a day or two. Your care team will instruct you on what to watch for at home and when to
call the clinic or emergency services.

Common Side Effects of Tysabri Infusions

Like every MS therapy, Tysabri has a long side-effect list. Not everyone experiences these, but it’s important to
know what’s possible.

More Common, Mild to Moderate Side Effects

Reported common side effects include:

• Headache
• Fatigue or feeling “wiped out” after infusion
• Joint or body aches
• Nausea
• Skin rash or itching
• Flushing or warmth
• Mild infusion reactions, such as dizziness or chills
• Increased risk of common infections, such as respiratory infections or urinary tract infections

These side effects are usually manageable. Your healthcare team might recommend strategies such as hydration, rest
after the infusion, over-the-counter pain relievers (if appropriate), or adjusting your routine on infusion days.

Infusion Reactions

Infusion reactions can happen during or soon after the IV drip. You should immediately report symptoms like:

• Hives, swelling, or severe itching
• Shortness of breath or chest tightness
• Severe dizziness or feeling faint
• High fever or shaking chills

Staff at the infusion center are trained to manage these reactions and may slow or stop the infusion, give
medication such as antihistamines or steroids, and monitor you more closely.

Serious Risks: PML and Other Safety Concerns

PML (Progressive Multifocal Leukoencephalopathy)

The most talked-about risk of Tysabri is progressive multifocal leukoencephalopathy (PML), a rare
but potentially life-threatening brain infection caused by reactivation of the JC virus. PML can lead to severe
disability or death.

Your PML risk is influenced by several factors:

• JCV antibody status and index. Testing positive for JC virus antibodies and having a higher index value is associated with increased risk.
• Duration of Tysabri therapy. Risk rises after about two years (24 months) of treatment.
• Past use of other immunosuppressant drugs. Prior treatments like certain chemotherapy agents or strong immune-suppressing medications can add to the risk.

Because of this, patients on Tysabri are monitored closely through the TOUCH program, periodic MRIs, regular
neurological exams, and repeat JCV antibody testing.

Early PML symptoms can look a lot like MS activity, which is why it’s crucial to report any new or rapidly changing
symptoms, especially:

• Sudden weakness or clumsiness
• Vision changes that are different from your usual optic neuritis
• Changes in speech, confusion, or personality changes
• New trouble with balance or walking

If PML is suspected, Tysabri is typically stopped immediately and urgent evaluation is arranged, often including MRI
and spinal fluid testing.

Other Serious Side Effects

While less discussed than PML, other serious risks include:

• Severe liver injury: Signs can include yellowing of the skin or eyes (jaundice), dark urine, or severe fatigue.
• Serious infections: Because Tysabri affects how immune cells behave, your ability to fight certain infections may be reduced.
• Herpes infections of the brain and eye: These require urgent treatment.
• Severe allergic reactions: Rare but potentially life-threatening; usually occur shortly after infusion.

Your neurologist will weigh these risks against the potential benefits of better MS control. For some people with
aggressive disease, the benefit of fewer relapses and less disability may outweigh these risks; for others, a
different therapy may be safer.

Who Is (and Isn’t) a Good Candidate for Tysabri?

Tysabri is generally considered for adults with:

• Relapsing forms of MS with high disease activity, and
• Either an inadequate response to other therapies or a need for a high-efficacy option early on.

Your provider may be more cautious or avoid Tysabri if you:

• Are JCV antibody positive with a high index and have been on Tysabri for a long time
• Have a history of severe immunosuppression or serious infections
• Have had PML or certain other neurological conditions in the past
• Are unable to attend regular monitoring visits and MRI scans

Pregnancy and breastfeeding require individual discussion. Data are evolving, but potential risks to the fetus or
newborn need to be considered against the risk of uncontrolled MS activity if treatment is stopped.

Alternatives to Tysabri for MS Treatment

Tysabri is just one of several high-efficacy treatments for relapsing MS. Depending on your medical history and
preferences, your neurologist may also discuss options such as:

• Ocrelizumab (Ocrevus): An infusion therapy targeting B cells, usually given twice yearly.
• Ofatumumab (Kesimpta): A self-injectable B-cell therapy used once a month.
• Fumarates (e.g., dimethyl fumarate): Oral medications that modulate immune activity.
• S1P modulators (e.g., fingolimod, ozanimod): Oral therapies that “trap” certain white blood cells in lymph nodes.
• Other infusions or injectables: Such as alemtuzumab or cladribine, which are typically reserved for specific situations due to their own risk profiles.

Each option has its own set of benefits, side effects, monitoring requirements, and lifestyle implications. Tysabri
may be a good fit if you prefer predictable once-monthly infusions and your care team believes the
benefit–risk balance is favorable for you.

Real-World Experiences with Tysabri Infusion Therapy

Statistics and risk tables are important, but they don’t tell you what it’s actually like to live on a once-monthly
infusion schedule. While everyone’s journey is unique, a few common themes tend to show up when people describe
their Tysabri experience.

“Infusion Day Became Part of My Routine”

Many people describe Tysabri day as a kind of “MS maintenance appointment.” Over time, the process becomes familiar:

• You know the nurses by name.
• You have a favorite chair at the infusion center.
• You bring a bag with snacks, headphones, and maybe that book you swear you’re going to finish this year.

Some patients plan infusion days on a Friday, so any post-infusion fatigue can be slept off over the weekend. Others
choose midweek mornings and head back to work afterward. You’ll figure out what works best once you see how your
body responds.

Energy Levels: The “Infusion Hangover” vs. the “Infusion Boost”

Experiences vary wildly. Some people report feeling a bit “hungover” the day after an infusionextra tired, slightly
off, and ready for a day of low expectations and comfortable sweatpants. Others feel surprisingly energized, as if
their MS symptoms are dialed down a notch for the next few weeks.

Keeping a simple symptom diaryon paper, in a notes app, or via an MS-specific tracking appcan help you spot
patterns in your energy and symptoms throughout each four-week cycle.

Emotional Impact: Less Relapse Anxiety, New Monitoring Anxiety

For many people, Tysabri brings psychological relief. Fewer relapses and fewer new MRI lesions can translate into
less anxiety about waking up with a suddenly numb leg or blurry vision. That’s a big deal for mental health and
quality of life.

On the flip side, the specter of PML riskand all the testing that comes with itcan create a different kind of
anxiety. People often talk about the mixed emotions surrounding:

• Waiting for JCV antibody results
• Going for frequent MRIs
• Discussing risk numbers that sound tiny but very serious (like “11 per 1,000”)

It’s completely valid to have complicated feelings about this. A good neurologist will make time to walk you through
your individual risk profile and answer questions in plain languagenot just rattle off statistics.

Planning Life Around a Once-Monthly Medical Appointment

Tysabri’s monthly schedule can affect practical life stuff: travel plans, work projects, and even family events.
People often:

• Schedule vacations around infusion dates
• Coordinate rides to and from the infusion center on days they expect to feel tired
• Talk with employers or HR about recurring medical time off once a month

The upside? Once you know your schedule, it’s predictable. You don’t have to remember a daily pill or a weekly shot;
you just commit to one infusion day roughly every four weeks.

Tips from the Infusion Chair

While every patient’s experience is different, some commonly shared tips include:

• Hydrate the day before and day of infusion. It can make IV placement easier and help you feel better afterward.
• Eat a light meal before you go. An empty stomach plus nerves plus medications is not a fun combo.
• Bring comfort items. A hoodie, blanket, or neck pillow can transform the chair into a cozy nook.
• Prepare questions ahead of time. Keep a running list on your phone to discuss with your nurse or neurologist.
• Have a “Plan B” day. If you feel more tired than usual after infusion, it’s okay to cancel social plans and prioritize rest.

Finding Community

MS can be isolating, and navigating a treatment as complex as Tysabri sometimes feels like learning a new language.
Many people find it helpful to connect with:

• Local or online MS support groups
• Patient communities focused on infusion therapies
• Educational materials from organizations like the National MS Society or MS-focused charities

Hearing how others balance risk, monitoring, and everyday life can make your own decisions feel less overwhelming
and remind you that you’re not walking this path alone.

When to Call Your Healthcare Team

On Tysabri, your neurologist and infusion nurses become key players on your “life with MS” team. Contact them right
away if you notice:

• Any new or rapidly worsening neurological symptoms
• Signs of infection, such as fever, severe chills, or unexplained cough
• Yellowing of the skin/eyes, very dark urine, or severe upper abdominal pain
• Severe infusion reactions (trouble breathing, swelling, hives)
• Major mood changes, confusion, or personality shifts

Don’t worry about “bothering” your care teamthat’s literally what they are there for. When in doubt, call.

Bottom Line

Tysabri infusion therapy for MS treatment is a powerful option that can dramatically reduce
relapses and MRI activity for many people with relapsing forms of MS. It works by blocking certain immune cells from
crossing into the central nervous system, helping to calm down inflammation at its source.

At the same time, it carries serious risksmost notably PMLthat require structured monitoring, informed consent,
and honest, ongoing conversations with your neurologist. If you’re considering Tysabri, think of it as a partnership
between you, your healthcare team, and a carefully regulated medication program. Together, the goal is to strike the
best possible balance between controlling MS now and protecting your long-term safety.

Ask questions, read reliable information, and consider both the numbers and how they feel to you. MS may be
unpredictable, but your treatment decisions don’t have to be made in the dark.